Subsequently, we show that radiosensitivity of OPSCC spheroids can be increased by PARP inhibition (olaparib and talazoparib), particularly within a larger number of relatively radioresistant HPV-negative HNSCC spheroids, and that this is evident in response to both x-rays and protons. The gene discussed is PARP1; the disease is head and neck squamous cell carcinoma.